Mad Money: Key points from September 28, 2021 (Tuesday) episode

Home Forums Investments in the US Summary of CNBC “Mad Money” Episodes Mad Money: Key points from September 28, 2021 (Tuesday) episode

  • This topic is empty.
Viewing 0 reply threads
  • Author
    • #4307

      This page contains summary of CNBC program “Mad Money w/ Jim Cramer” which was on air on Tuesday, September 28, 2021.  It also contains links to CNBC sites which contain video clips and transcripts are also listed.


      (1) Jim Cramer says he’s keeping new money ‘on the sidelines’ until the stock sell-off ends (

      • “At this point, it’s only safe to buy the stuff that’s been completely mauled or could be coiled springs,” CNBC’s Jim Cramer said Monday.
      • The “Mad Money” host said he believes eventually the stock market sell-off will “right itself.”
      • “I just think it’s worth waiting on the sidelines with new money until we figure out how things can turn around

      What’s behind the downturn?: (i) Accelerating inflation, (ii) Natural gas prices soaring, (iii) Supply chain nightmare, (iv) Covid-induced labor shortage, (v) Impact of infrastructure bill, (vi) Chip shortage


      (2) Executive Interview: Sonos CEO says this is the most challenging time he’s ever seen for tech companies (

      Patrick Spence, the chief executive officer of Sonos, told “Mad Money” host Jim Cramer on Tuesday the tech industry in the most challenging period he’s ever seen.

      Ticker: SONO


      (3) Off-the-Chart: Charts suggest these four growth stocks are worth buying into weakness, says Jim Cramer (

      • “The charts — as interpreted by Bob Lang — suggest that Affirm, Asana, Upstart and InMode are worth buying into weakness,” CNBC’s Jim Cramer said Tuesday.
      • “I’ve seen Lang make these calls before after monster sell-offs, and he’s been spot on,” the “Mad Money” host said.

      Ticker: AFRM, ASAN, UPST, INMO


      (4) Cramer says ‘steer clear’ of Warby Parker on public debut unless the stock trades at obvious discount (

      • CNBC’s Jim Cramer advised investors to be careful about buying shares of Warby Parker ahead of the eyeglass retailer’s scheduled direct listing Wednesday.
      • “I think you should steer clear of Warby Parker unless it falls below that [$40] reference price and you can get it in the $30s,” the “Mad Money” host said.

      Ticker: WRBY [The company will direct listing tomorrow]


      (5) Cramer’s lightning round: Cytokinetics is a very good speculative play (

      • Cytokinetics: “This is early stage, and here’s what’s interesting about this company: Once again we find these companies that big pharma needs. This is a very good spec. Small molecule therapeutics. The big companies, the Pfizers, love these guys.”
      • “I’ve been watching LZ. It’s going nowhere fast. It’s going nowhere fast. You can’t touch it. It has no backing on Wall Street, none whatsoever.”
      • Matterport: “3D cameras are very, very hot, but they’re too hot for me. I’m going to have to take a pass.”

      Ticker: CYTK, LZ, MTTR


      (6) [No Video Clip] Cramer’s take on labor shortage 


      Other Stocks Discussed (Calls with Audiences): GAP (GPS), Pfizer (PFE),  Snap (SNAP) [good shape]


      Ref: Links to other sites that relate to episode of September 28, 2021



      Previous episode Next Episode



Viewing 0 reply threads
  • The topic ‘Mad Money: Key points from September 28, 2021 (Tuesday) episode’ is closed to new replies.